Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Coptis chinensis is a traditional Chinese medicinal herb containing berberine as its primary bioactive alkaloid. Berberine exhibits anti-inflammatory and hepatoprotective effects by inhibiting pro-inflammatory cytokines and modulating liver enzyme activity.
Origin & History
Coptis chinensis, commonly known as Coptis or Huang Lian, is a perennial herbaceous plant in the Ranunculaceae family native to China, with its rhizome (Coptidis Rhizoma) used medicinally. The rhizome is harvested and processed into powder, pills, decoctions, or tablets, often with wine, ginger juice, or Evodia rutaecarpa for specific therapeutic effects.
Research Narrative (Provisional)
Current research on Coptis chinensis lacks human clinical trials, RCTs, or meta-analyses, with evidence limited to preclinical studies in cell cultures and animal models. Animal studies demonstrate anti-inflammatory and hepatoprotective effects, but no PubMed PMIDs for human trials are available in the current research.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Coptis chinensis (Huang Lian) is utilized as a medicinal herb rather than a food source, so conventional macronutrient profiling (carbohydrates, fats, protein) is not clinically relevant at typical therapeutic doses (1.5–10 g dried rhizome/day in traditional practice). Its pharmacological value derives from its rich alkaloid and bioactive compound content: Primary Bioactive Alkaloids (collectively 5–8% of dried rhizome weight): • Berberine: 4.0–7.5% of dried rhizome (the dominant and most studied alkaloid; typical concentrations ~50–90 mg/g depending on cultivar, harvest time, and processing) • Coptisine: 0.5–2.0% of dried rhizome • Palmatine: 0.5–1.5% of dried rhizome • Jatrorrhizine: 0.2–0.8% of dried rhizome • Epiberberine: 0.3–1.0% of dried rhizome • Columbamine: trace to 0.3% • Magnoflorine: trace amounts Other Bioactive Compounds: • Ferulic acid and other phenolic acids (minor amounts) • Lignans (woorenoside, etc.): trace quantities • Polysaccharides: present in the rhizome matrix, though not well-quantified for immunomodulatory activity • Organic acids including chlorogenic acid: trace amounts • Small amounts of volatile oils Mineral Content (approximate, per dried rhizome): • Potassium, calcium, magnesium, iron, manganese, and zinc are present in small quantities typical of plant rhizomes, but are not considered nutritionally significant at medicinal doses Fiber & Carbohydrates: • Crude fiber and starch are present in the dried rhizome but are not relevant at therapeutic doses Bioavailability Notes: • Berberine has notoriously low oral bioavailability (~5% or less in humans) due to extensive first-pass metabolism by CYP2D6, CYP1A2, and CYP3A4, poor intestinal absorption, and P-glycoprotein-mediated efflux • Gut microbiota convert berberine to dihydroberberine in the intestinal lumen, which is absorbed ~5-fold more efficiently and then re-oxidized to berberine in enterocytes • Berberine undergoes significant enterohepatic recirculation, which extends its effective half-life • Co-administration with P-glycoprotein inhibitors or lipid-based formulations can enhance berberine bioavailability • Coptisine and palmatine share similar bioavailability challenges as isoquinoline alkaloids • Traditional decoction preparation (boiling in water for 15–30 minutes) efficiently extracts water-soluble alkaloids; berberine extraction yield increases with decoction time up to a plateau • The Chinese Pharmacopoeia (2020 edition) requires a minimum berberine hydrochloride content of 5.5% in quality Coptis chinensis rhizome
Reported Mechanism (Provisional)
Berberine, the main alkaloid in Coptis chinensis, inhibits nuclear factor-kappa B (NF-κB) signaling pathways, reducing production of inflammatory cytokines including IL-1β, TNF-α, and IL-6. The compound also modulates liver enzyme activity by protecting hepatocytes from oxidative stress and reducing inflammatory cascade activation. Berberine additionally affects AMPK (adenosine monophosphate-activated protein kinase) pathways, contributing to its hepatoprotective mechanisms.
Clinical Narrative (Provisional)
Current evidence for Coptis chinensis comes primarily from animal studies rather than human clinical trials. Rat models of arthritis showed significant reductions in inflammatory markers when treated with Coptis extracts. Cholestasis studies in rats demonstrated decreased liver enzymes (ALT and AST) and reduced bilirubin levels compared to control groups. Human clinical data remains limited, with most research focusing on berberine as an isolated compound rather than whole Coptis preparations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.